Biomarkers have the potential to transform the detection, treatment, and outcomes of liver
transplant complications, though their application is limited because of the lack of …

Bile acids have received increasing attention as a marker of the long-term prognosis and a
potential therapeutic target in patients with biliary atresia, which is a progressive disease of …

Despite advances in posttransplant care, long-term outcomes for liver transplant recipients
remain unchanged. Approximately 25% of recipients will advance to graft cirrhosis and …

Abstract Context Serum Mac-2 binding protein glycosylation isomer (M2BPGi)
concentrations are known to be an indicator of chronic liver injury and fibrosis. Objective …

Background The relationship between liver fibrosis and inflammation and Mac-2-binding
protein glycosylation isomer (M2BPGi) in patients with chronic liver disease (CLD) other …

Objective This study aimed to assess the accuracy of Mac-2 binding protein glycosylation
isomer (M2BPGi) in predicting the stage of liver fibrosis. Methods Articles published until …

Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA+-M2BP) is a
novel marker for evaluating fibrosis and predicting the development of hepatocellular …

Background Patients who undergo pediatric living donor liver transplantation (LDLT)
sometimes develop graft fibrosis. Recently, Mac-2 binding protein glycosylation-modified …

Liver biopsy remains key in the evaluation of hepatic dysfunction in liver transplant
recipients. Concerns about its invasive nature and potential risks limit its acceptance by …

Purpose: To determine if machine learning can be leveraged to develop non-invasive
diagnostic tools for liver graft fibrosis. Methods: Using 1,804 ultrasound (US) studies from …